These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9817973)

  • 1. Altered proliferative and metastatic potential associated with increased expression of syndecan-1.
    Hirabayashi K; Numa F; Suminami Y; Murakami A; Murakami T; Kato H
    Tumour Biol; 1998; 19(6):454-63. PubMed ID: 9817973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of syndecan-1 expression confer potent serum-dependent growth in human 293T cells.
    Numa F; Hirabayashi K; Tsunaga N; Kato H; O'Rourke K; Shao H; Stechmann-Lebakken C; Varani J; Rapraeger A; Dixit VM
    Cancer Res; 1995 Oct; 55(20):4676-80. PubMed ID: 7553648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of syndecan-1 proteoglycan in the invasiveness of HT-1080 fibrosarcoma].
    Péterfia B; Hollósi P; Szilák L; Timár F; Paku S; Jeney A; Kovalszky I
    Magy Onkol; 2006; 50(2):115-20. PubMed ID: 16888674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas.
    Mikami S; Ohashi K; Usui Y; Nemoto T; Katsube K; Yanagishita M; Nakajima M; Nakamura K; Koike M
    Jpn J Cancer Res; 2001 Oct; 92(10):1062-73. PubMed ID: 11676857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syndecan-1 expression is diminished in acantholytic cutaneous squamous cell carcinoma.
    Bayer-Garner IB; Sanderson RD; Smoller BR
    J Cutan Pathol; 1999 Sep; 26(8):386-90. PubMed ID: 10551410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of syndecan-2 in regulation of actin-cytoskeletal organization of Lewis lung carcinoma-derived metastatic clones.
    Munesue S; Kusano Y; Oguri K; Itano N; Yoshitomi Y; Nakanishi H; Yamashina I; Okayama M
    Biochem J; 2002 Apr; 363(Pt 2):201-9. PubMed ID: 11931647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced expression of syndecan-1 affects metastatic potential and clinical outcome in patients with colorectal cancer.
    Fujiya M; Watari J; Ashida T; Honda M; Tanabe H; Fujiki T; Saitoh Y; Kohgo Y
    Jpn J Cancer Res; 2001 Oct; 92(10):1074-81. PubMed ID: 11676858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteoglycans and WT1 as markers for distinguishing adenocarcinoma, epithelioid mesothelioma, and benign mesothelium.
    Gulyás M; Hjerpe A
    J Pathol; 2003 Apr; 199(4):479-87. PubMed ID: 12635139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syndecan-1 expressed in Schwann cells causes morphological transformation and cytoskeletal reorganization and associates with actin during cell spreading.
    Carey DJ; Stahl RC; Cizmeci-Smith G; Asundi VK
    J Cell Biol; 1994 Jan; 124(1-2):161-70. PubMed ID: 8294499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of syndecan-1 (CD138) in nasopharyngeal carcinoma is correlated with advanced stage and poor prognosis.
    Chen CL; Ou DL
    Hum Pathol; 2006 Oct; 37(10):1279-85. PubMed ID: 16949936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of syndecans, a heparan sulfate proteoglycan, in malignant gliomas: participation of nuclear factor-kappaB in upregulation of syndecan-1 expression.
    Watanabe A; Mabuchi T; Satoh E; Furuya K; Zhang L; Maeda S; Naganuma H
    J Neurooncol; 2006 Mar; 77(1):25-32. PubMed ID: 16132527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactivity to cell surface syndecans in cytoplasm and nucleus: tubulin-dependent rearrangements.
    Brockstedt U; Dobra K; Nurminen M; Hjerpe A
    Exp Cell Res; 2002 Apr; 274(2):235-45. PubMed ID: 11900484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of syndecan-1 is preferentially reduced compared with that of E-cadherin in acantholytic squamous cell carcinoma.
    Bayer-Garner IB; Smoller BR
    J Cutan Pathol; 2001 Feb; 28(2):83-9. PubMed ID: 11168756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane-anchored proteoglycans of mouse macrophages: P388D1 cells express a syndecan-4-like heparan sulfate proteoglycan and a distinct chondroitin sulfate form.
    Yeaman C; Rapraeger AC
    J Cell Physiol; 1993 Nov; 157(2):413-25. PubMed ID: 8227171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma.
    Mukunyadzi P; Liu K; Hanna EY; Suen JY; Fan CY
    Mod Pathol; 2003 Aug; 16(8):796-801. PubMed ID: 12920224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of syndecan-1 mRNA in cervical-carcinoma cells is involved with the 3' untranslated region.
    Nakanishi K; Yoshioka N; Oka K; Hakura A
    Int J Cancer; 1999 Feb; 80(4):527-32. PubMed ID: 9935152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syndecan-1 expression in mammary epithelial tumor cells is E-cadherin-dependent.
    Leppä S; Vleminckx K; Van Roy F; Jalkanen M
    J Cell Sci; 1996 Jun; 109 ( Pt 6)():1393-403. PubMed ID: 8799827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel laminin-binding form of syndecan-1 (cell surface proteoglycan) produced by syndecan-1 cDNA-transfected NIH-3T3 cells.
    Salmivirta M; Mali M; Heino J; Hermonen J; Jalkanen M
    Exp Cell Res; 1994 Nov; 215(1):180-8. PubMed ID: 7957667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localisation of specific heparan sulfate proteoglycans during the proliferative phase of brain development.
    Ford-Perriss M; Turner K; Guimond S; Apedaile A; Haubeck HD; Turnbull J; Murphy M
    Dev Dyn; 2003 Jun; 227(2):170-84. PubMed ID: 12761845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 regulates expression of the syndecan-1 proteoglycan on B lymphoid cells.
    Sneed TB; Stanley DJ; Young LA; Sanderson RD
    Cell Immunol; 1994 Feb; 153(2):456-67. PubMed ID: 8118875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.